GKHT Medical Technology Co., Ltd. (SHE:301370)
China · Delayed Price · Currency is CNY 8.69
0.00 (0.00%)
At close: Sep 4, 2026
GKHT Medical Technology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 4,058 | 5,454 | 5,043 | 7,614 | - | - | |
Market Cap Growth | -23.44% | 8.15% | -33.77% | - | - | - |
Enterprise Value | 4,901 | 6,016 | 5,516 | 8,718 | - | - |
Last Close Price | 8.69 | 11.52 | 10.56 | 15.65 | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 168.09 | 80.03 | 38.60 | 49.48 | - | - |
PS Ratio | 0.63 | 0.78 | 0.69 | 1.02 | - | - |
PB Ratio | 1.62 | 2.14 | 1.97 | 2.99 | - | - |
P/TBV Ratio | 1.74 | 2.28 | 2.14 | 3.26 | - | - |
P/FCF Ratio | 9.26 | 8.44 | 8.32 | 13.54 | - | - |
P/OCF Ratio | 6.84 | 8.04 | 7.77 | 10.62 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.76 | 0.86 | 0.75 | 1.17 | - | - |
EV/EBITDA Ratio | 31.31 | 37.66 | 19.23 | 23.65 | - | - |
EV/EBIT Ratio | 53.34 | 47.78 | 24.01 | 26.70 | - | - |
EV/FCF Ratio | 11.19 | 9.31 | 9.10 | 15.50 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.57 | 0.45 | 0.57 | 0.54 | 1.74 | 1.68 |
Debt / EBITDA Ratio | 9.11 | 5.57 | 4.26 | 3.19 | 6.45 | 5.74 |
Debt / FCF Ratio | 3.25 | 1.76 | 2.40 | 2.44 | 12.67 | 16.85 |
Net Debt / Equity Ratio | 0.32 | 0.16 | 0.30 | 0.34 | 1.34 | 1.44 |
Net Debt / EBITDA Ratio | 6.01 | 2.54 | 2.65 | 2.34 | 5.74 | 5.36 |
Net Debt / FCF Ratio | 1.84 | 0.63 | 1.25 | 1.53 | 9.75 | 14.42 |
Asset Turnover | 1.01 | 1.08 | 1.08 | 1.04 | 0.91 | 0.90 |
Inventory Turnover | 2.19 | 2.42 | 2.45 | 2.35 | 1.87 | 1.75 |
Quick Ratio | 0.58 | 0.69 | 0.66 | 0.64 | 0.54 | 0.52 |
Current Ratio | 1.49 | 1.51 | 1.50 | 1.44 | 1.20 | 1.21 |
Return on Equity (ROE) | 0.65% | 2.53% | 5.93% | 8.31% | 9.41% | 13.05% |
Return on Assets (ROA) | 0.90% | 1.21% | 2.10% | 2.84% | 2.87% | 3.49% |
Return on Invested Capital (ROIC) | 0.96% | 2.81% | 5.48% | 6.69% | 6.49% | 7.90% |
Return on Capital Employed (ROCE) | 3.50% | 4.60% | 8.40% | 12.10% | 18.50% | 24.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.66% | 1.25% | 2.59% | 2.02% | - | - |
FCF Yield | 10.80% | 11.85% | 12.02% | 7.39% | - | - |
Dividend Yield | 1.39% | 1.06% | 0.80% | 0.75% | - | - |
Payout Ratio | 297.19% | 98.68% | 84.61% | 64.72% | 97.68% | 85.17% |
Buyback Yield / Dilution | -12.18% | -4.31% | -9.17% | -6.08% | -1.26% | -0.83% |
Total Shareholder Return | -10.79% | -3.26% | -8.38% | -5.33% | -1.26% | -0.83% |